Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

25
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

24
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
24
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

34
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

41
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
41
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

31
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Malperfusion Post-Aortic Dissection Repair With the AMDS Hybrid Prosthesis: The DARTS Trial Post Hoc Analysis.

JACC. Advances·2026
Same author

Strategies to Reduce Gender Discrimination in Surgery: A Qualitative Study of Women Neurosurgeons and Cardiothoracic Surgeons.

Journal of surgical education·2026
Same author

Investigating Physical Exercise and Cognitive Training Effects on Cognition and Brain Health in Men and Women with Heart Failure: The ReCARDIO Trial.

CJC open·2026
Same authorSame journal

Cognition in Chronic Heart Failure: Advancing Knowledge for Better Prevention Through Remote Assessment.

CJC open·2026
Same author

A Response to the Letter to the Editor: "Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?"

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Primary Paget-like intraepithelial glandular lesion of the bronchus: report of a first case.

American journal of clinical pathology·2026

Related Experiment Video

Updated: Aug 16, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.1K

Amyloid Deposits in a Functionally Unicuspid Stenotic Aortic Valve.

Anne-Sophie Zenses1, Charles Leduc2, Stéphanie Béchard3

  • 1Research Centre of the University of Montreal Hospital (CRCHUM), Montreal, Quebec, Canada.

CJC Open
|December 23, 2022
PubMed
Summary

This study reports the first case of localized amyloidosis in a calcified, unicuspid aortic valve, suggesting a link between unusual valve structure and amyloid development.

More Related Videos

Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

2.8K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.4K

Related Experiment Videos

Last Updated: Aug 16, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.1K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

2.8K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.4K

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Biochemistry

Background:

  • Aortic stenosis commonly involves myocardial transthyretin protein amyloidosis.
  • Dystrophic valvular amyloidosis is typically associated with fibrocalcific valve disease.

Observation:

  • This is the first reported case of localized amyloidosis of indeterminate type.
  • The amyloidosis occurred in a severely calcified, functionally unicuspid aortic valve.

Findings:

  • The case suggests dystrophic amyloidosis can occur in non-tricuspid aortic valves.
  • Altered hemodynamic stress due to unusual valve morphology may contribute to amyloid development.

Implications:

  • This finding challenges current understanding of valvular amyloidosis pathophysiology.
  • It highlights the role of unique aortic valve anatomy in disease development.
  • Further research into hemodynamic factors in amyloidosis is warranted.